These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7572423)

  • 1. Interleukin-10 and its implications for immunopathology.
    Goldman M; Velu T
    Adv Nephrol Necker Hosp; 1995; 24():79-90. PubMed ID: 7572423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dependability of the immune system and the problem of secondary immunologic deficiency].
    Shirinskiĭ VS
    Vestn Akad Med Nauk SSSR; 1991; (12):43-5. PubMed ID: 1801473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of interleukin-10 in the regulation of immune responses in infectious diseases].
    Goldman M; Marchant A; Florquin S; Velu T
    Rev Med Brux; 1994; 15(2):61-5. PubMed ID: 8029574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inconspicuous diseases of Ch. Nicolle; superimposed diseases are the cause of immunity failures].
    Giroud P; Jadin JB
    Arch Inst Pasteur Tunis; 1986 Mar; 63(1):97-9. PubMed ID: 3778032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems of immunodepression by various causes and a risk of infection].
    Sakiyama Y
    Kango Gijutsu; 1987 Sep; 33(12):1377-81. PubMed ID: 3682358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppression induced by homologous blood transfusion].
    Fariñas Guerrero F; Muñoz Gómez M; García Vallejo JJ; Ruiz Romero de la Cruz MD; Morell Ocaña M
    Sangre (Barc); 1998 Jun; 43(3):213-7. PubMed ID: 9741228
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles of interleukin-10 in acute graft-versus-host disease and graft rejection.
    Ju X; Wang J; Xu B; Cao Y; Lü S
    Chin Med J (Engl); 2003 Apr; 116(4):534-7. PubMed ID: 12875717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection.
    Mulligan MS; Warner RL; McDuffie JE; Bolling SF; Sarma JV; Ward PA
    Exp Mol Pathol; 2000 Aug; 69(1):1-9. PubMed ID: 10891287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged amelioration of acute lung allograft rejection by overexpression of human interleukin-10 under control of a long acting ubiquitin C promoter in rats.
    Stammberger U; Bilici M; Gugger M; Gazdhar A; Hamacher J; Hyde SC; Schmid RA
    J Heart Lung Transplant; 2006 Dec; 25(12):1474-9. PubMed ID: 17178344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 as an anti-stress cytokine.
    Goldman M; Stordeur P
    Eur Cytokine Netw; 1997 Sep; 8(3):301-2. PubMed ID: 9346367
    [No Abstract]   [Full Text] [Related]  

  • 11. On the mechanisms of T cell silencing by IL-10 DNA: direct and indirect inhibition of T cell functions.
    Eo SK; Chun S; Lee S; Rouse BT
    Cell Immunol; 2000 Nov; 206(1):59-69. PubMed ID: 11161438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodeficiency syndromes and recurrent infection.
    Gaspar HB; Goldblatt D
    Br J Hosp Med; 1997 Dec; 58(11):565-8. PubMed ID: 10193471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipient intramuscular cotransfection of transforming growth factor beta1 and interleukin 10 ameliorates acute lung graft rejection.
    Suda T; Daddi N; Tagawa T; Kanaan SA; Kozower BD; Ritter JH; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):926-31. PubMed ID: 15821665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective role of interleukin-10 in endotoxin shock.
    Marchant A; Bruyns C; Vandenabeele P; Abramowicz D; Gérard C; Delvaux A; Ghezzi P; Velu T; Goldman M
    Prog Clin Biol Res; 1994; 388():417-23. PubMed ID: 7831374
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-10 (IL-10) prevents primary nonfunction in allogeneic islet transplantation.
    Chao SH; Chu SH; Lee SC; Lin JK; Chen KM
    Transplant Proc; 1995 Feb; 27(1):602-4. PubMed ID: 7879114
    [No Abstract]   [Full Text] [Related]  

  • 16. Derangement of immune responses by myeloid suppressor cells.
    Serafini P; De Santo C; Marigo I; Cingarlini S; Dolcetti L; Gallina G; Zanovello P; Bronte V
    Cancer Immunol Immunother; 2004 Feb; 53(2):64-72. PubMed ID: 14593498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor macrophages.
    Eisenstein TK
    Immunol Ser; 1994; 60():203-24. PubMed ID: 8251569
    [No Abstract]   [Full Text] [Related]  

  • 19. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
    Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
    J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.
    Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC
    Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.